Page 111 - Science

RESEARCH | REPORT

8. A. B. Shanafelt et al., Nat. Biotechnol. 18, 1197–1202 22. S. Atwell, M. Ultsch, A. M. De Vos, J. A. Wells, Science 278, research grant (J.T.S., A.R., and K.C.G.); NIH grant R35 CA197633,
(2000). 1125–1128 (1997). the Ressler Family Fund, and the Parker Institute for Cancer
9. M. Rickert, M. J. Boulanger, N. Goriatcheva, K. C. Garcia, 23. D. M. Spencer, T. J. Wandless, S. L. Schreiber, G. R. Crabtree, Immunotherapy (G.P. and A.R.); the Sean N. Parker Autoimmunity
J. Mol. Biol. 339, 1115–1128 (2004). Science 262, 1019–1024 (1993). Research Laboratory (J.A.B.); and fellowship support from Stanford
10. E. Roessler et al., Proc. Natl. Acad. Sci. U.S.A. 91, 3344–3347 24. D. J. Mandell, T. Kortemme, Nat. Chem. Biol. 5,797–807 (2009). Molecular and Cellular Immunobiology NIH training grant 5T32
(1994). 25. G. T. Kapp et al., Proc. Natl. Acad. Sci. U.S.A. 109, 5277–5282 AI072905 and a PhRMA Foundation Translational Medicine and
11. R. Moriggl et al., Immunity 10, 249–259 (1999). (2012). Therapeutics postdoctoral award (J.T.S.). J.A.B. and A.R. are
12. T. R. Malek, Annu. Rev. Immunol. 26, 453–479 (2008). 26. J. S. Park et al., Proc. Natl. Acad. Sci. U.S.A. 111, 5896–5901 members of the Parker Institute for Cancer Immunotherapy. K.C.G.,
13. D. Klatzmann, A. K. Abbas, Nat. Rev. Immunol. 15, 283–294 (2014). J.T.S., I.C.K., and D.B. are inventors on patent applications 62/217,364
(2015). 27. S. M. Lewis et al., Nat. Biotechnol. 32, 191–198 (2014). and 62/375,089 submitted by Stanford University that cover the
14. S. Amu, I. Gjertsson, A. Tarkowski, M. Brisslert, Scand. J. 28. C. Y. Wu, K. T. Roybal, E. M. Puchner, J. Onuffer, W. A. Lim, use of orthogonal cytokine-receptor pairs for use in cellular
Immunol. 64, 482–492 (2006). Science 350, aab4077 (2015). immunotherapy.
15. O. Boyman, J. Sprent, Nat. Rev. Immunol. 12, 180–190
(2012). ACKNOWLEDGMENTS SUPPLEMENTARY MATERIALS
16. L. Gattinoni et al., J. Exp. Med. 202, 907–912 (2005). We thank M. McCracken for expertise in T cell immunotherapy; www.sciencemag.org/content/359/6379/1037/suppl/DC1
17. J. T. Sockolosky, F. C. Szoka, Adv. Drug Deliv. Rev. 91, 109–124 N. Saligrama, A. Cravens, M. Hollander, F. Zhao, Y. Rosenberg- Materials and Methods
(2015). Hasson, and the Stanford Human Immune Monitoring Core (HIMC) Figs. S1 to S18
18. E. F. F. Zhu et al., Cancer Cell 27, 489–501 (2015). for technical assistance; and R. Fernandes for helpful discussion. References (29–35)
19. W. W. Overwijk et al., J. Exp. Med. 198, 569–580 (2003). The data presented in this paper are tabulated in the main text and
20. K. Sakuishi et al., J. Exp. Med. 207, 2187–2194 (2010). supplementary materials. Supported by NIH grants R37 AI051321 30 October 2017; accepted 11 January 2018
21. M. G. J. Baud et al., Science 346, 638–641 (2014). and HHMI (K.C.G.); a 2016 Stanford Cancer Institute translational 10.1126/science.aar3246 Downloaded from

http://science.sciencemag.org/

on March 1, 2018

Sockolosky et al., Science 359, 1037–1042 (2018) 2 March 2018 6of 6